Qudexy XR is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in people two years of age and older. Qudexy XR is also referred to by its drug name, topiramate.
Qudexy XR is an anticonvulsant, or in other words, a drug used to prevent and control seizures. It is believed to work in cases of epilepsy by inhibiting nerve signals in the brain.
How do I take it?
Prescribing information states that Qudexy XR is taken orally as an extended-release tablet once daily.
The FDA-approved label for Qudexy XR lists common side effects including “pins and needles” sensations, loss of appetite, weight loss, speech disorders and related speech problems, fatigue, dizziness, sleepiness, nervousness, slowed movements, abnormal vision, and fever.
Rare but serious side effects listed for Qudexy XR include elevated or lowered body temperature, high body acid levels, cognitive dysfunction, fetal harm, suicidal thoughts and behavior, kidney stones, high body ammonia levels, and severe eye problems potentially leading to permanent vision loss.
For more details about this treatment, visit:
Qudexy XR — Upsher-Smith
Topiramate XR — Epilepsy Foundation